TUM – Technical University of Munich Menu
The new SFB lead by Prof. Stefan Engelhardt of TUM investigates the molecular regulation in the cardiovascular system.
The new SFB lead by Prof. Stefan Engelhardt of TUM investigates the molecular regulation in the cardiovascular system.
Image: ediundsepp
  • Research news
  • reading time: 3 MIN

New collaborative research center at the TUM

The German Research Foundation funds research into molecular regulation in the cardiovascular system

The German Research Foundation has approved funding for a new collaborative research center (“Sonderforschungsbereich”, short “SFB”) at the behest of the Technical University of Munich (TUM), Goethe University Frankfurt and other partners. Over the next four years, the 30-partner consortium will investigate the role of non-coding RNAs in the cardiovascular system and will receive funding of around 11 million euros for this purpose. In addition, funding will be extended for an existing SFB under TUM leadership and a transregional SFB in which the TUM is involved.

Ribonucleic acid, or RNA for short, has long been known to be an intermediate step in the transmission of genetic information for protein synthesis. It has now also been established that every cell in the body contains thousands of different RNA molecules that do not code for proteins but instead regulate cellular processes. Non-coding RNAs are causatively related to cardiovascular diseases – still the leading cause of death worldwide.

Stefan Engelhardt is Professor of Pharmacology and Toxicology at the TUM and spokesperson for the new transregional SFB TRR 267 – “Non-coding RNA in der Cardiovascular System”. Together with colleagues from Munich, Frankfurt, Bad Nauheim and Hanover, he plans to investigate the relationship between non-coding RNAs and cardiovascular diseases over the next four years. The research will focus primarily on how non-coding RNAs are synthesized and transported, how they influence cellular processes and what role they play in the development and healing of cardiovascular diseases. A long-term goal is to identify target molecules for new treatments.

The co-spokesperson is Professor Stefanie Dimmeler of the Institute for Cardiovascular Regeneration at Johann Wolfgang Goethe University in Frankfurt. Ludwig Maximilian University Munich (LMU), the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Hanover Medical School are also partners in the new SFB.

Funding extended for CRCs for plant research and meteorology

What molecular mechanisms determine crop yield and pest and drought resistance in plants? SFB 924 – “Molecular Mechanisms Regulating Yield and Yield Stability in Plants” – is headed by Claus Schwechheimer, Professor of Plant Systems Biology at the TUM School of Life Sciences in Weihenstephan, who has been investigating the subject since 2011. The SFB will now receive a third round of funding for four more years.

The transregional SFB TRR165 – “Waves to Weather” − in which the TUM is involved, conducts research into the scientific basis for creating new and better weather forecasting systems. The team plans to shine a light on the complex interactions of physical processes and learn how they contribute to the development of, for example, hail storms, hurricanes and monsoons. The German Research Foundation has granted the CFC a second round of funding for the next four years.

Corporate Communications Center

Technical University of Munich Dr. Vera Siegler
vera.siegler(at)tum.de
Tel: +49 (0) 89 289 23325

Article at tum.de

Ein Stent.

Advantage of coating lost after first year

In bypass surgery, alternative routes are built around blocked heart vessels. Yet new occlusions can occur in bypasses. To re-open them, doctors use stents, sometimes coated with drugs to prevent constriction. Researchers...

Arbeiten mit Zellkulturen sind in der onkologischen Grundlagenforschung ein wichtiges Werkzeug. (Bild: A. Heddergott / TUM)

TUM coordinates two new Collaborative Research Centers

The Technical University of Munich (TUM) has taken on the role of coordinator in two new German Research Foundation Collaborative Research Centers (short SFB for german ‘Sonderforschungsbereich’), both of which are...

Prof. Stefan Engelhardt (r.) mit Petros Avramopoulos.

Suppression of miR-29 protects against cardiac fibrosis

Cardiac fibrosis involves an increase of connective tissue in the cardiac muscle, causing a loss of function. A team of researchers at the Technical University of Munich (TUM) has now discovered that microRNA 29 (miR-29)...

Ein Bild eines menschliches Skelett mit künstlichen Halsschlagadern.

microRNA may reduce stroke risk

The molecule microRNA-210 stabilises deposits in the carotid artery and can prevent them from tearing. Thus, it may prevent dangerous blood clots from forming. This is what scientists headed by Prof. Lars Mägdefessel,...